Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Diabetes

Free Subscription Articles published in Retina Retrieve available abstracts of 92 articles: HTML format

Single Articles

April 2024
1. SU T, Lai D, Wu Y, Gu C, et al
   COMPARISON OF THE EFFICACY AND SAFETY OF RANIBIZUMAB 0.5 MG VERSUS 1.0 MG WITH PARS PLANA VITRECTOMY FOR THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY: A Randomized Controlled Trial.
   Retina. 2024;44:680-688.
   PubMed     Abstract available
   
   
   March 2024
2. ZENG Y, Wen F, Zhuang X, He G, et al
   Epiretinal Macrophage-like Cells on Optical Coherence Tomography: Potential Inflammatory Imaging Biomarker of Severity in Diabetic Retinopathy.
   Retina. 2024 Mar 12. doi: 10.1097/IAE.0000000000004100.
   PubMed     Abstract available
   
   
   
3. BALAS M, Issa M, Popovic MM, Moayad L, et al
   Adaptive Optics Imaging in Diabetic Retinopathy: A Prospective Cohort Study.
   Retina. 2024 Mar 12. doi: 10.1097/IAE.0000000000004088.
   PubMed     Abstract available
   
   
   
4. ZUR D, Hod K, Trivizki O, Rabinovitch D, et al
   Anti-Vascular Endothelial Growth Factor Treatment in Diabetic Macular Edema-Results from a Large Single Center Cohort with Bevacizumab As First-Line Therapy.
   Retina. 2024 Mar 12. doi: 10.1097/IAE.0000000000004096.
   PubMed     Abstract available
   
   
   February 2024
5. KHANNA S, Shaw L, Hyman MJ, Zhang J, et al
   ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT.
   Retina. 2024;44:205-213.
   PubMed     Abstract available
   
   
   January 2024
6. LIN Z, Li D, Lin W, Wen L, et al
   The impact of bilateral vision status on vision-related quality of life in people with diabetes mellitus.
   Retina. 2024 Jan 8. doi: 10.1097/IAE.0000000000004047.
   PubMed     Abstract available
   
   
   December 2023
7. GUO Y, Zheng X, He H, Zheng S, et al
   Retinal Microvasculopathy with Different Insulin Infusion Therapies in Children with Type 1 Diabetes Mellitus without Clinical Diabetic Retinopathy.
   Retina. 2023 Dec 21. doi: 10.1097/IAE.0000000000004028.
   PubMed     Abstract available
   
   
   
8. SANTOS AR, Almeida AC, Rocha AC, Reste-Ferreira D, et al
   Central and Peripheral Involvement of the Retina in the Initial Stages of Diabetic Retinopathy.
   Retina. 2023 Dec 8. doi: 10.1097/IAE.0000000000004021.
   PubMed     Abstract available
   
   
   November 2023
9. HUANG RS, Mihalache A, Popovic MM, Munn C, et al
   Association of Intravenous Fluorescein Angiography and Adaptive Optics Imaging in Diabetic Retinopathy: A Prospective Case Series.
   Retina. 2023 Nov 28. doi: 10.1097/IAE.0000000000004012.
   PubMed     Abstract available
   
   
   
10. ZANG B, Rong S, Wang Y, Feng K, et al
    Association of Diabetic Macular Edema with Quality of Life in Type 2 diabetes patients: The Fushun Diabetic Retinopathy Cohort Study.
    Retina. 2023 Nov 8. doi: 10.1097/IAE.0000000000003992.
    PubMed     Abstract available
    
    
    
11. AIELLO LP, Jacoba CMP, Ashraf M, Cavallerano JD, et al
    INTEGRATING MACULAR OPTICAL COHERENCE TOMOGRAPHY WITH ULTRAWIDE-FIELD IMAGING IN A DIABETIC RETINOPATHY TELEMEDICINE PROGRAM USING A SINGLE DEVICE.
    Retina. 2023;43:1928-1935.
    PubMed     Abstract available
    
    
    September 2023
12. SHAW L, Khanna S, Hyman MJ, Ham S, et al
    Interactions of Metformin and Other Medications in Reducing the Odds of Age-Related Macular Degeneration in a Diabetic Cohort.
    Retina. 2023 Sep 26. doi: 10.1097/IAE.0000000000003949.
    PubMed     Abstract available
    
    
    August 2023
13. LEE MY, Han K, Koo HYR, Yu DS, et al
    Psoriasis increases retinal vein occlusion risk in diabetic patients: A nationwide population-based study.
    Retina. 2023 Aug 21. doi: 10.1097/IAE.0000000000003916.
    PubMed     Abstract available
    
    
    
14. BOWE T, Mahmoudzadeh R, Soares RR, Nguyen MK, et al
    Characteristics of Participants in Diabetic Retinopathy Clinical Research Clinical Trials Who Were Lost to Follow up.
    Retina. 2023 Aug 15. doi: 10.1097/IAE.0000000000003911.
    PubMed     Abstract available
    
    
    
15. VUJOSEVIC S, Ting DS
    Is central retina thickness the most relevant parameter in the management of diabetic macular edema?
    Retina. 2023 Aug 15. doi: 10.1097/IAE.0000000000003914.
    PubMed    
    
    
    July 2023
16. L S, Banerjee M, Venkatesh P, Azad SV, et al
    Assessment of Quality and Adequacy of Pan Retinal Photocoagulation in Proliferative Diabetic Retinopathy using Ultra-wide Field Imaging.
    Retina. 2023 Jul 19. doi: 10.1097/IAE.0000000000003902.
    PubMed     Abstract available
    
    
    
17. AIELLO LP, Jacoba CMP, Ashraf M, Cavallerano JD, et al
    Integrating Macular Optical Coherence Tomography with Ultrawide Field Imaging in a Diabetic Retinopathy Telemedicine Program Using a Single Device.
    Retina. 2023 Jul 4. doi: 10.1097/IAE.0000000000003883.
    PubMed     Abstract available
    
    
    
18. GERARDO GS, Chow DR
    Shovel and Cut Technique: Beveled Vitrectomy Probes to Address Diabetic Tractional Retinal Detachments.
    Retina. 2023;43:1207-1208.
    PubMed     Abstract available
    
    
    June 2023
19. VUJOSEVIC S, Toma C, Villani E, Nucci P, et al
    Longitudinal microvascular and neuronal retinal evaluation in patients with diabetes mellitus type 1 and 2 and good glycemic control.
    Retina. 2023 Jun 27. doi: 10.1097/IAE.0000000000003880.
    PubMed     Abstract available
    
    
    May 2023
20. SAUER L, Vitale AS, Jacoby RS, Hart B, et al
    Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Macular Telangiectasia Type 2 (MacTel) Patients with and without Diabetes.
    Retina. 2023 May 29. doi: 10.1097/IAE.0000000000003851.
    PubMed     Abstract available
    
    
    
21. ARRUABARRENA C, Rodriguez-Miguel A, Allendes G, Vera C, et al
    EVALUATION OF THE INCLUSION OF SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN A TELEMEDICINE DIABETIC RETINOPATHY SCREENING PROGRAM: A REAL CLINICAL PRACTICE.
    Retina. 2023 May 4. doi: 10.1097/IAE.0000000000003832.
    PubMed     Abstract available
    
    
    
22. GONZALEZ VH, Luo C, Almeida DRP, Cutino A, et al
    Better baseline vision leads to better outcomes after the 0.19-mg fluocinolone acetonide intravitreal implant in diabetic macular edema.
    Retina. 2023 May 1. doi: 10.1097/IAE.0000000000003827.
    PubMed     Abstract available
    
    
    April 2023
23. KIM K, Kim ES, Yu SY
    Prediction of Diabetic Retinopathy Severity Using a Combination of Retinal Neurodegeneration and Capillary Nonperfusion on OCT Angiography.
    Retina. 2023 Apr 27. doi: 10.1097/IAE.0000000000003820.
    PubMed     Abstract available
    
    
    
24. RUSH RB, Gomez PL, Rush SW, Bastar PG, et al
    Internal Limiting Membrane Peeling in Patients Undergoing Vitrectomy for Tractional Retinal Detachment Secondary to Diabetic Retionpathy.
    Retina. 2023 Apr 15. doi: 10.1097/IAE.0000000000003812.
    PubMed     Abstract available
    
    
    
25. OPHIR A
    CORRESPONDENCE Regarding the article: Mylonas et al. The impact of the vitreomacular interface on functional and anatomical outcomes in diabetic macular edema treated with three different anti-VEGF agents: post hoc analysis of the Protocol T study. Re
    Retina. 2023 Apr 6. doi: 10.1097/IAE.0000000000003803.
    PubMed    
    
    
    
26. MYLONAS G, Najeeb BH, Goldbach F, Deak GG, et al
    Reply to comment to: The impact of the vitreomacular interface on functional and anatomical outcomes in diabetic macular edema treated with three different anti-VEGF agents: post hoc analysis of the Protocol T study.
    Retina. 2023 Apr 6. doi: 10.1097/IAE.0000000000003804.
    PubMed    
    
    
    
27. SINGARAVELU J, Oakey ZB, Wrenn JM, Singh AD, et al
    Intravitreal Fluocinolone Acetonide Implant for Radiation Retinopathy: Report of Preliminary Findings.
    Retina. 2023 Apr 6. doi: 10.1097/IAE.0000000000003808.
    PubMed     Abstract available
    
    
    March 2023
28. MATHIS T, Rezkallah A, Ricard C, Vartin C, et al
    Real world study comparing phakic versus pseudophakic eyes in diabetic macular oedema treated with dexamethasone implant: The PHAKIDEX Study.
    Retina. 2023 Mar 27. doi: 10.1097/IAE.0000000000003787.
    PubMed    
    
    
    
29. LIN Z, Li D, Wen L, Wang Y, et al
    Association of ocular perfusion pressure and cerebrospinal fluid pressure with changes in diabetic retinopathy.
    Retina. 2023 Mar 27. doi: 10.1097/IAE.0000000000003792.
    PubMed     Abstract available
    
    
    
30. ERSOZ MG, Kirik F, Isik B, Ozdemir H, et al
    Henle's Fiber Layer Thickness and Area Measurement in Type 2 Diabetes Mellitus with and without Retinopathy Using a Modified Directional Optical Coherence Tomography Strategy.
    Retina. 2023 Mar 9. doi: 10.1097/IAE.0000000000003778.
    PubMed     Abstract available
    
    
    
31. ROHOWETZ LJ, Patel V, Sridhar J, Yannuzzi NA, et al
    Valsalva Retinopathy: Clinical Features and Treatment Outcomes.
    Retina. 2023 Mar 8. doi: 10.1097/IAE.0000000000003772.
    PubMed     Abstract available
    
    
    
32. ROMANO F, Cozzi M, Monteduro D, Oldani M, et al
    NATURAL COURSE AND CLASSIFICATION OF EXTENSIVE MACULAR ATROPHY WITH PSEUDODRUSEN-LIKE APPEARANCE.
    Retina. 2023;43:402-411.
    PubMed     Abstract available
    
    
    
33. TAN SZ, Dell' Aversana Orabona G, Robins JJ, Kumaran N, et al
    "Delamination Plus": A Technique to Reduce Immediate Postoperative Diabetic Cavity Hemorrhage.
    Retina. 2023;43:520-522.
    PubMed     Abstract available
    
    
    February 2023
34. LE D, Dadzie A, Son T, Lim JI, et al
    Comparative Analysis of OCT and OCT Angiography Characteristics in Early Diabetic Retinopathy.
    Retina. 2023 Feb 7. doi: 10.1097/IAE.0000000000003761.
    PubMed     Abstract available
    
    
    
35. IMAI H, Tetsumoto A, Inoue S, Takano F, et al
    Intraoperative Three-Dimensional Fluorescein Angiography-Guided Pars Plana Vitrectomy for the Treatment of Proliferative Diabetic Retinopathy: The Maximized Utility of the Digital Assisted Vitrectomy.
    Retina. 2023;43:359-362.
    PubMed     Abstract available
    
    
    January 2023
36. WEIR NL, Guan W, Karger AB, Klein B, et al
    Omega-3 fatty acids are associated with decreased presence and severity of diabetic retinopathy: A Combined Analysis of MESA and GOLDR Cohorts.
    Retina. 2023 Jan 30. doi: 10.1097/IAE.0000000000003745.
    PubMed     Abstract available
    
    
    
37. ROHART C, Le HM, Estrada-Walker J, Giocanti-Auregan A, et al
    Long-term Prognosis of Choroidal Neovascularization Complicating Angioid Streaks.
    Retina. 2023 Jan 23. doi: 10.1097/IAE.0000000000003746.
    PubMed     Abstract available
    
    
    
38. CHANDRAN K, Giridhar A, Gayathri MS, Antison M, et al
    OUTER FOVEAL DEFECTS IN TYPE-2 MACULAR TELANGIECTASIA.
    Retina. 2023;43:111-119.
    PubMed     Abstract available
    
    
    December 2022
39. SUN JK, Beaulieu WT, Melia M, Ferris FL 3rd, et al
    Defining "Strong" versus "Weak" Response to Anti-VEGF Treatment for Center-Involved Diabetic Macular Edema.
    Retina. 2022 Dec 29. doi: 10.1097/IAE.0000000000003730.
    PubMed     Abstract available
    
    
    
40. LI G, Ho M, Li S, Chen L, et al
    Comparing functional and vascular layer outcomes of laser photocoagulation versus subthreshold micropulse laser for diabetic m.
    Retina. 2022 Dec 26. doi: 10.1097/IAE.0000000000003711.
    PubMed     Abstract available
    
    
    
41. SCHONBACH E, Knight DK, Wu CY, Arevalo JF, et al
    Direct Macular Hole Manipulation Results in High Success Rate in Secondary Macular Hole Repair.
    Retina. 2022 Dec 21. doi: 10.1097/IAE.0000000000003712.
    PubMed     Abstract available
    
    
    
42. ZHANG S, Zhu Z, Bulloch G, Guo X, et al
    PROGRESSIVE PERIPAPILLARY CHOROID THINNING AND RETINAL NEURODEGENERATION IN PATIENTS WITH DIABETES: A 3-Year Cohort Study.
    Retina. 2022;42:2401-2410.
    PubMed     Abstract available
    
    
    November 2022
43. SALABATI M, Mahmoudzadeh R, Starr MR, Zhang Q, et al
    REFRACTIVE ERROR CHANGE DURING TREATMENT OF DIABETIC MACULAR EDEMA: A Post Hoc Analysis of the Diabetic Retinopathy Clinical Research Protocol T Trial.
    Retina. 2022;42:2059-2065.
    PubMed     Abstract available
    
    
    October 2022
44. DHOOT DS, Moini H, Reed K, Silva FQ, et al
    Incidence of New Diabetic Macular Edema in Fellow Eyes of Patients in the VISTA and VIVID Studies.
    Retina. 2022 Oct 17. pii: 00006982-990000000-00186.
    PubMed     Abstract available
    
    
    
45. NAKANO H, Hasebe H, Murakami K, Nakamura Y, et al
    Choroidal vascular density in diabetic retinopathy assessed with swept-source optical coherence tomography.
    Retina. 2022 Oct 10. pii: 00006982-990000000-00171.
    PubMed     Abstract available
    
    
    
46. YAN Y, Zhu L, Zeng M, Huang Z, et al
    COMBINATION OF VITRECTOMY AND INTENTIONAL MACULAR DETACHMENT IS ASSOCIATED WITH A FASTER EDEMATOUS REGRESSION THAN VITRECTOMY ALONE IN THE TREATMENT OF REFRACTORY DIABETIC MACULAR EDEMA.
    Retina. 2022;42:1859-1866.
    PubMed     Abstract available
    
    
    August 2022
47. CAMP DA, Price DA, Neiweem AE, Jusufbegovic D, et al
    Effects of intravitreal bevacizumab therapy on glomerular filtration rate in patients treated for proliferative diabetic retinopathy.
    Retina. 2022 Aug 17. pii: 00006982-990000000-00094.
    PubMed     Abstract available
    
    
    
48. MANSOUR HA, Mahmoudzadeh R, Hsu J
    Intraocular Fibrin Glue to Lower Risk of Postoperative Vitreous Hemorrhage After Diabetic Pars Plana Vitrectomy.
    Retina. 2022 Aug 15. doi: 10.1097/IAE.0000000000003597.
    PubMed     Abstract available
    
    
    
49. MYLONAS G, Najeeb BH, Goldbach F, Deak GG, et al
    The impact of the vitreomacular interface on functional and anatomical outcomes in diabetic macular edema treated with three different anti-VEGF agents: post hoc analysis of the Protocol T study.
    Retina. 2022 Aug 12. pii: 00006982-990000000-00117.
    PubMed     Abstract available
    
    
    June 2022
50. TANDIAS R, Lemire CA, Palvadi K, Arroyo JG, et al
    POSTERIOR VITREOUS DETACHMENT STATUS AS A PREDICTIVE FACTOR FOR OUTCOMES OF VITRECTOMY FOR DIABETIC VITREOUS HEMORRHAGE.
    Retina. 2022;42:1103-1110.
    PubMed     Abstract available
    
    
    
51. SHAHRAKI T, Arabi A, Nourinia R, Beheshtizadeh NF, et al
    PANRETINAL PHOTOCOAGULATION VERSUS INTRAVITREAL BEVACIZUMAB VERSUS A PROPOSED MODIFIED COMBINATION THERAPY FOR TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY: A Randomized Three-Arm Clinical Trial (CTPDR Study).
    Retina. 2022;42:1065-1076.
    PubMed     Abstract available
    
    
    May 2022
52. DEANS JR, George R, Aldaas K, Van Buren ED, et al
    Increased Distance from Clinic Leads to Higher Loss to Follow-up after Pars Plana Vitrectomy in Diabetic Patients.
    Retina. 2022 May 23. pii: 00006982-990000000-00072.
    PubMed     Abstract available
    
    
    
53. BERROCAL MH, Acaba-Berrocal L
    Minimal, relaxing membranectomies for the management of opacified hyaloid with diabetic tractional retinal detachments in monocular patients: a novel surgical technique.
    Retina. 2022 May 12. pii: 00006982-990000000-00063.
    PubMed     Abstract available
    
    
    
54. KARAHAN E, Vural GS, Girgin Y, Kayikcioglu OC, et al
    PARS PLANA VITRECTOMY WITH and WITHOUT ILM-PEELING for DIABETIC PATIENTS with MACULA INVOLVED TRACTIONAL RETINAL DETACHMENT.
    Retina. 2022 May 12. pii: 00006982-990000000-00062.
    PubMed     Abstract available
    
    
    
55. WANG W, Chen Y, Kun X, Gong X, et al
    Flow and geometrical alterations in retinal microvasculature correlated with the occurrence of diabetic retinopathy: evidence from a longitudinal study.
    Retina. 2022 May 2. pii: 00006982-990000000-00053.
    PubMed     Abstract available
    
    
    April 2022
56. KESIM C, Bektas SN, Kulali Z, Yildiz E, et al
    Henle Fiber Layer Mapping with Directional Optical Coherence Tomography.
    Retina. 2022 Apr 26. pii: 00006982-990000000-00048.
    PubMed     Abstract available
    
    
    
57. PERAIS JA, McCullough PG, McLaughlin GA, Pritchard EWJ, et al
    Predictive factors associated with anatomical and functional outcomes following panretinal photocoagulation in people with proliferative diabetic retinopathy.
    Retina. 2022 Apr 22. pii: 00006982-990000000-00043.
    PubMed     Abstract available
    
    
    
58. ARRIGO A, Aragona E, Bandello F
    Reply: Foveal Muller cell cone as a prognostic optical coherence tomography biomarker for initial response to antivascular endothelial growth factor treatment in cystoid diabetic macular edema.
    Retina. 2022 Apr 8. pii: 00006982-990000000-00030.
    PubMed    
    
    
    
59. CHOI M, Kim SW
    Reply: Foveal Muller cell cone as a prognostic optical coherence tomography biomarker for initial response to antivascular endothelial growth factor treatment in cystoid diabetic macular edema.
    Retina. 2022 Apr 8. pii: 00006982-990000000-00031.
    PubMed    
    
    
    
60. MARTIN-GUTIERREZ MP, Vermeirsch S, Chandra S, Kumar Agarwal AA, et al
    Retinal non-perfusion in the ETDRS seven fields compared with widefield fluorescein angiography: correlation and use of extrapolation factor.
    Retina. 2022 Apr 4. pii: 00006982-990000000-00026.
    PubMed     Abstract available
    
    
    
61. MAZLOUMI M, Entezari M, Samadikhadem S, Ramezani A, et al
    SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS OF RETINAL HYPERPERMEABILITY AND CHOROIDAL INFLAMMATION AS PREDICTORS OF SHORT-TERM FUNCTIONAL AND ANATOMICAL OUTCOMES IN EYES WITH DIABETIC MACULAR EDEMA TREATED WITH INTRAVITREAL BEVACIZUMAB.
    Retina. 2022;42:760-766.
    PubMed     Abstract available
    
    
    March 2022
62. SILVA PS, Liu D, Glassman AR, Aiello LP, et al
    Assessment of Fluorescein Angiography Nonperfusion in Eyes with Diabetic Retinopathy using Ultrawide Field Retinal Imaging.
    Retina. 2022 Mar 24. pii: 00006982-990000000-00013.
    PubMed     Abstract available
    
    
    
63. LE D, Son T, Lim JI, Yao X, et al
    Quantitative optical coherence tomography reveals rod photoreceptor degeneration in early diabetic retinopathy.
    Retina. 2022 Mar 11. pii: 00006982-990000000-00004.
    PubMed     Abstract available
    
    
    
64. RUSH RB, Rush SW, Reinauer RM, Bastar PG, et al
    Vitrectomy for Diabetic Complications: A Pooled Analysis of Randomized Controlled Trials Utilizing Modern Techniques and Equipment.
    Retina. 2022 Mar 8. pii: 00006982-990000000-00002.
    PubMed     Abstract available
    
    
    
65. KIRTHI V, Zuckerman BP, Alam U, Bunce C, et al
    ASSOCIATIONS BETWEEN DYSGLYCEMIA, RETINAL NEURODEGENERATION, AND MICROALBUMINURIA IN PREDIABETES AND TYPE 2 DIABETES.
    Retina. 2022;42:442-449.
    PubMed     Abstract available
    
    
    
66. LV B, Li S, Liu Y, Wang W, et al
    DEVELOPMENT AND VALIDATION OF AN EXPLAINABLE ARTIFICIAL INTELLIGENCE FRAMEWORK FOR MACULAR DISEASE DIAGNOSIS BASED ON OPTICAL COHERENCE TOMOGRAPHY IMAGES.
    Retina. 2022;42:456-464.
    PubMed     Abstract available
    
    
    February 2022
67. BROWN DM, Boyer DS, Csaky K, Vitti R, et al
    Intravitreal Nesvacumab (Anti-Angiopoietin 2) Plus Aflibercept in Diabetic Macular Edema: The Phase 2 RUBY Randomized Trial.
    Retina. 2022 Feb 22. pii: 00006982-900000000-95242.
    PubMed     Abstract available
    
    
    
68. XIONG K, Wang W, Gong X, Ji Y, et al
    INFLUENCE OF HIGH MYOPIA ON CHORIOCAPILLARIS PERFUSION AND CHOROIDAL THICKNESS IN DIABETIC PATIENTS WITHOUT DIABETIC RETINOPATHY.
    Retina. 2022 Feb 7. pii: 00006982-900000000-95272.
    PubMed     Abstract available
    
    
    
69. QIN YJ, Zhang YL, Zhang YQ, He BT, et al
    Elevated level of uric acid, but not glucose, in aqueous humor as a risk factor for diabetic macular edema in patients with type 2 diabetes.
    Retina. 2022 Feb 7. pii: 00006982-900000000-95267.
    PubMed     Abstract available
    
    
    
70. GABRIELLE PH, Nguyen V, Creuzot-Garcher C, Arnold JJ, et al
    TITLE: THREE-YEAR TREATMENT OUTCOMES OF AFLIBERCEPT VERSUS RANIBIZUMAB FOR DIABETIC MACULAR EDEMA: DATA FROM THE FIGHT RETINAL BLINDNESS! REGISTRY.
    Retina. 2022 Feb 7. pii: 00006982-900000000-95264.
    PubMed     Abstract available
    
    
    
71. GIUFFRIDA FP, Leone G, Mainetti C, Galli D, et al
    Response to treatment of choroidal neovascularization in highly myopic eyes with dome-shaped macula: 2 years of follow-up.
    Retina. 2022 Feb 7. pii: 00006982-900000000-95269.
    PubMed     Abstract available
    
    
    January 2022
72. GUO X, Lu X, Zhang B, Hu X, et al
    Automatic detection and grading of diabetic macular edema based on deep neural network.
    Retina. 2022 Jan 31. pii: 00006982-900000000-95277.
    PubMed     Abstract available
    
    
    
73. VENKATESH R, Mangla R, Mishra P, Nahata H, et al
    Bridge arch-shaped subretinal fluid in neovascular age-related macular degeneration - evolution and outcomes.
    Retina. 2022 Jan 31. pii: 00006982-900000000-95278.
    PubMed     Abstract available
    
    
    
74. WANG Y, Toyama T, Hashimoto Y, Kawai H, et al
    Association of prediabetes with retinal microvasculature on swept-source optical coherence tomography angiography in the elderly: OTASSHA study.
    Retina. 2022 Jan 20. pii: 00006982-900000000-95284.
    PubMed     Abstract available
    
    
    December 2021
75. PAWLOFF M, Bogunovic H, Gruber A, Michl M, et al
    A systematic correlation of central subfield thickness (CSFT) with retinal fluid volumes quantified by deep learning in the major exudative macular diseases.
    Retina. 2021 Dec 17. pii: 00006982-900000000-95316.
    PubMed     Abstract available
    
    
    
76. KWON JW, Park YG
    Clinical features of intravitreal dexamethasone implantation in vitrectomized eyes of patients with diabetic macular edema.
    Retina. 2021 Dec 2. pii: 00006982-900000000-95326.
    PubMed     Abstract available
    
    
    
77. ZARRANZ-VENTURA J, Nguyen V, Creuzot-Garcher C, Verbraak F, et al
    International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry.
    Retina. 2021 Dec 1. pii: 00006982-900000000-95334.
    PubMed     Abstract available
    
    
    November 2021
78. RUSSELL JF, Zhou H, Shi Y, Shen M, et al
    Longitudinal Analysis of Diabetic Choroidopathy in Proliferative Diabetic Retinopathy Treated with Panretinal Photocoagulation Using Widefield Swept Source OCT.
    Retina. 2021 Nov 26. pii: 00006982-900000000-95337.
    PubMed     Abstract available
    
    
    
79. FAN W, Nittala MG, Wykoff CC, Brown DM, et al
    A NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRA-WIDE FIELD FLUORESCEIN ANGIOGRAPHY: RECOVERY STUDY.
    Retina. 2021 Nov 19. pii: 00006982-900000000-95349.
    PubMed     Abstract available
    
    
    
80. KIM JT, Park EJ
    Correlation of Photoreceptor Integrity with Retinal Vessel Density and Choriocapillaris in Eyes with Diabetic Retinopathy.
    Retina. 2021 Nov 2. pii: 00006982-900000000-95357.
    PubMed     Abstract available
    
    
    October 2021
81. RICHEY BF, Obrock RS, Gee ZM, Lu DY, et al
    Smoking, Rural Residence and Diabetes as Risk Factors for Presumed Ocular Histoplasmosis Syndrome.
    Retina. 2021 Oct 15. pii: 00006982-900000000-95383.
    PubMed     Abstract available
    
    
    August 2021
82. RUSH RB, Rush SW
    Outcomes in Patients Resuming Intravitreal Anti-VEGF Therapy Following Treatment Delay during the COVID-19 Pandemic.
    Retina. 2021 Aug 2. pii: 00006982-900000000-95424.
    PubMed     Abstract available
    
    
    May 2021
83. RUSH RB, Del Valle Penella A, Reinauer RM, Rush SW, et al
    INTERNAL LIMITING MEMBRANE PEELING DURING VITRECTOMY FOR DIABETIC VITREOUS HEMORRHAGE: A Randomized Clinical Trial.
    Retina. 2021;41:1118-1126.
    PubMed     Abstract available
    
    
    
84. FURINO C, Boscia F, Niro A, D'Addario M, et al
    DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification.
    Retina. 2021;41:1102-1109.
    PubMed     Abstract available
    
    
    
85. MIMOUNI M, Naftali Ben Haim L, Rozenberg E, Shapira Y, et al
    SELF-DESIGNATION OF THE TREATED EYE BEFORE INTRAVITREAL INJECTIONS: Prevalence and Predictors of Incorrect Calling.
    Retina. 2021;41:1005-1009.
    PubMed     Abstract available
    
    
    April 2021
86. IMAI H, Tetsumoto A, Yamada H, Hayashida M, et al
    LONG-TERM EFFECT OF CYSTOTOMY WITH OR WITHOUT THE FIBRINOGEN CLOT REMOVAL FOR REFRACTORY CYSTOID MACULAR EDEMA SECONDARY TO DIABETIC RETINOPATHY.
    Retina. 2021;41:844-851.
    PubMed     Abstract available
    
    
    
87. 
    A New Era in Reducing Treatment Burden in Retinal Disease.
    Retina. 2021;41.
    PubMed    
    
    
    March 2021
88. ALAM M, Le D, Lim JI, Yao X, et al
    VASCULAR COMPLEXITY ANALYSIS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF DIABETIC RETINOPATHY.
    Retina. 2021;41:538-545.
    PubMed     Abstract available
    
    
    February 2021
89. JAMALI H, Eslami J, Kalashipour F, Nowroozzadeh MH, et al
    EFFECT OF PANRETINAL PHOTOCOAGULATION ON CORNEAL SENSATION AND TEAR FUNCTION IN PATIENTS WITH DIABETIC RETINOPATHY.
    Retina. 2021;41:338-344.
    PubMed     Abstract available
    
    
    January 2021
90. KIM YK, An Y, Park SP
    INTRAOCULAR AND INTEROCULAR DIFFERENCES IN PARAFOVEAL VASCULAR DENSITY IN DIABETIC PATIENTS WITHOUT DIABETIC RETINOPATHY.
    Retina. 2021;41:170-180.
    PubMed     Abstract available
    
    
    November 2020
91. RUSH RB, Del Valle Penella A, Reinauer RM, Rush SW, et al
    Silicone Oil versus Perfluoropropane Gas Tamponade during Vitrectomy for Tractional Retinal Detachment or Fibrous Proliferation: a Randomized Clinical Trial.
    Retina. 2020 Nov 23. doi: 10.1097/IAE.0000000000003052.
    PubMed     Abstract available
    
    
    May 2020
92. BRITO PS, Costa JV, Barbosa-Matos C, Costa SM, et al
    ASSOCIATION OF SERUM VASOGENIC AND PROINFLAMMATORY FACTORS WITH CLINICAL RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR DIABETIC MACULAR EDEMA.
    Retina. 2020 May 20. doi: 10.1097/IAE.0000000000002852.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge.